H. Pehamberger

发表

Epiluminescence microscopy-based classification of pigmented skin lesions using computerized image analysis and an artificial neural network

H. Kittler, M. Binder, A. Seeber, 1998, Melanoma research.

Diagnostic accuracy of dermoscopy.

H. Kittler, M. Binder, H. Pehamberger, 2002, The Lancet. Oncology.

Accuracy of computer diagnosis of melanoma: a quantitative meta-analysis.

S. Menzies, H. Kittler, M. Binder, 2003, Archives of dermatology.

Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists.

M. Binder, A. Steiner, H. Pehamberger, 1995, Archives of dermatology.

Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet.

M. G. Fleming, R. Hofmann-Wellenhof, H. Cabo, 2003, Journal of the American Academy of Dermatology.

Compliance with follow-up and prognosis among patients with thin melanomas.

H. Kittler, M. Binder, H. Pehamberger, 2001, European journal of cancer.

Reevaluation of the ABCD rule for epiluminescence microscopy.

H. Kittler, M. Binder, A. Steiner, 1999, Journal of the American Academy of Dermatology.

Morphologic changes of pigmented skin lesions: a useful extension of the ABCD rule for dermatoscopy.

H. Kittler, M. Binder, H. Pehamberger, 1999, Journal of the American Academy of Dermatology.

Azidothymidine inhibits melanoma cell growth in vitro and in vivo

H. Pehamberger, J. Humer, B. Ferko, 2008, Melanoma research.

NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

Andreas Sommer, H. Pehamberger, H. Beug, 2004 .

Application of an artificial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study

M. Binder, A. Steiner, H. Pehamberger, 1994, The British journal of dermatology.

Epiluminescence microscopy. A useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists.

M. Binder, A. Steiner, H. Pehamberger, 1995, Archives of dermatology.

Guidelines on the use of extracorporeal photopheresis

A. Enk, C. Klemke, H. Pehamberger, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Three‐dimensional multiphoton/optical coherence tomography for diagnostic applications in dermatology

M. Binder, H. Pehamberger, W. Drexler, 2013, Journal of biophotonics.

Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.

H. Kittler, M. Binder, H. Pehamberger, 2000, Journal of the American Academy of Dermatology.

Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters.

H. Pehamberger, E. Kubista, C. Singer, 2006, European journal of gynaecological oncology.

In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions.

K Wolff, A. Steiner, H. Pehamberger, 1987, Journal of the American Academy of Dermatology.

Novel CDKN2A mutations in Austrian melanoma patients

H. Pehamberger, S. Burgstaller-Muehlbacher, M. Marko, 2015, Melanoma research.

Terminology in surface microscopy. Consensus meeting of the Committee on Analytical Morphology of the Arbeitsgemeinschaft Dermatologische Forschung, Hamburg, Federal Republic of Germany, Nov. 17, 1989.

J Smolle, W Stolz, H P Soyer, 1990, Journal of the American Academy of Dermatology.

Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pVIII-28aa phage peptide library.

H. Pehamberger, K. Wolff, F. Felici, 2002, The Journal of investigative dermatology.

Bcl‐XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy

H. Pehamberger, K. Wolff, B. Monia, 2002, International journal of cancer.

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

H. Pehamberger, K. Wolff, R. Bryan, 1998, Nature Medicine.

Compact, broad-bandwidth fiber laser for sub-2-microm axial resolution optical coherence tomography in the 1300-nm wavelength region.

W Drexler, H. Pehamberger, W. Drexler, 2003, Optics letters.

Elevated procaspase levels in human melanoma

H. Pehamberger, K. Wolff, H. Eichler, 2001, Melanoma research.

Statistical evaluation of epiluminescence microscopy criteria for melanocytic pigmented skin lesions.

K Wolff, M Schemper, M. Schemper, 1993, Journal of the American Academy of Dermatology.

In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma.

K Wolff, A. Steiner, H. Pehamberger, 1987, Journal of the American Academy of Dermatology.

In vivo epiluminescence microscopy: improvement of early diagnosis of melanoma.

K Wolff, M. Binder, A. Steiner, 1993, The Journal of investigative dermatology.

Computer-aided epiluminescence microscopy of pigmented skin lesions: the value of clinical data for the classification process

K Wolff, H. Kittler, M. Binder, 2000, Melanoma research.

Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: circulating anti-basement membrane zone antibodies; in vitro studies.

H. Pehamberger, K. Holubar, K. Konrad, 1980, The Journal of investigative dermatology.

Influence of increased c-Myc expression on the growth characteristics of human melanoma.

H. Pehamberger, K. Wolff, H. Eichler, 1999, The Journal of investigative dermatology.

The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells.

H. Pehamberger, V. Sexl, F. Roka, 2005, The Journal of investigative dermatology.

Proteomic identification of a marker signature for MAPKi resistance in melanoma

R. Aebersold, T. Mohr, H. Pehamberger, 2019, The EMBO journal.

Proteome profiling of keratinocytes transforming to malignancy

T. Mohr, H. Pehamberger, C. Gerner, 2015, Electrophoresis.

Who benefits most from adjuvant interferon treatment for melanoma?

A. Hauschild, H. Pehamberger, P. Ascierto, 2015, American journal of therapeutics.

IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma

H. Kittler, H. Pehamberger, P. Ferenci, 2014, PloS one.

Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.

A. Steiner, H. Pehamberger, H. Soyer, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Perspectives of pegylated interferon use in dermatological oncology.

H. Pehamberger, 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Wnt1 is anti-lymphangiogenic in a melanoma mouse model.

W. Berger, H. Pehamberger, A. Bracher, 2012, The Journal of investigative dermatology.

Randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM): Analysis of long-term survival.

H. Pehamberger, M. Gore, M. Millward, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R

H. Pehamberger, P. Valent, V. Wacheck, 2014, PloS one.

Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage

H. Pehamberger, T. Lucas, B. Jansen, 2002, Melanoma research.

Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans

H. Pehamberger, H. Eichler, W. Weninger, 1996, Antimicrobial agents and chemotherapy.

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

H. Pehamberger, K. Wolff, T. Lucas, 2000, The Lancet.

Infrared A radiation promotes survival of human melanocytes carrying ultraviolet radiation‐induced DNA damage

H. Pehamberger, D. Födinger, S. Kimeswenger, 2016, Experimental dermatology.

Bcl-xL Antisense Oligonucleotides Chemosensitize Human Glioblastoma Cells

H. Pehamberger, H. Eichler, B. Monia, 2002, Chemotherapy.

Mcl-1 Is a Novel Therapeutic Target for Human Sarcoma

H. Pehamberger, B. Monia, M. Wolschek, 2004, Clinical Cancer Research.

T-Cell Receptor Repertoire of Lymphocytes Infiltrating Cutaneous Melanoma Is Predominated by Va Specificities Present in T-Cells of Normal Human Skin1

H. Pehamberger, R. Strohal, L. Paucz, 2006 .

Immunohistological analysis of anti-melanoma host responses

H. Pehamberger, G. Stingl, R. Strohal, 2004, Archives of Dermatological Research.

Primary malignant melanoma of the vagina: long-term remission following radiation therapy.

H. Pehamberger, E. Petru, N. Vávra, 1998, Gynecologic oncology.

Increased nuclear volume in metastasizing "thick" melanomas.

M. Binder, A. Steiner, H. Pehamberger, 1996, The Journal of investigative dermatology.

T-Cell Receptor Repertoire of Lymphocytes Infiltrating Cutaneous Melanoma Is Predominated by Vα Specificities Present in T-Cells of Normal Human Skin

H. Pehamberger, G. Stingl, R. Strohal, 1994 .

Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis

H. Pehamberger, R. Knobler, C. Jantschitsch, 2015, Photodermatology, photoimmunology & photomedicine.

Comparison of the effects of three different treatment regimens of recombinant interferons (r-IFN α, r-IFN γ, and r-IFN α +cimetidine) in disseminated malignant melanoma

A. Steiner, H. Pehamberger, C. Wolf, 2004, Journal of Cancer Research and Clinical Oncology.

Perilesional injection of r-GM-CSF in patients with cutaneous melanoma metastases.

H. Pehamberger, K. Wolff, B. Jansen, 2001, The Journal of investigative dermatology.

Fotemustine plus dacarbazine in advanced stage III malignant melanoma.

M. Binder, H. Pehamberger, K. Wolff, 1992, European journal of cancer.

3,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.

H. Pehamberger, A. Riemer, T. Szekeres, 2010, The Journal of investigative dermatology.

A genetically engineered influenza A virus with ras-dependent oncolytic properties.

H. Pehamberger, R. Jakesz, A. García-Sastre, 2001, Cancer research.

N‐ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID‐hu mouse models

H. Pehamberger, K. Wolff, H. Eichler, 1996, International journal of cancer.

Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.

T. Mohr, H. Pehamberger, J. Drach, 2009, Journal of proteome research.

Trends in the diagnosis of melanoma at a university center over time

P. Tschandl, H. Kittler, H. Pehamberger, 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Management of Refractory Early-Stage Cutaneous T-Cell Lymphoma

H. Pehamberger, M. A. Huber, K. Scharffetter-Kochanek, 2006, American journal of clinical dermatology.

Actinic damage on the back is significantly determined by MC1R variants and previous sun exposure compared with other body sites in a multivariate analysis

H. Pehamberger, F. Roka, J. Wendt, 2014, The British journal of dermatology.

Suppression of mTOR complex 2‐dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002

H. Pehamberger, C. Thallinger, V. Wacheck, 2009, The British journal of dermatology.

Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice.

H. Pehamberger, K. Wolff, G. Klosner, 2000, The Journal of investigative dermatology.

Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.

H. Pehamberger, K. Wolff, B. Monia, 2003, The Journal of investigative dermatology.

HLA‐DR3 in dermatitis herpetiformis

H. Pehamberger, W. Mayr, K. Holubar, 1981, The British journal of dermatology.

Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.

H. Pehamberger, P. Valent, W. Sperr, 2014, American journal of blood research.

The Austrian Competence Network on Mastocytosis (AUCNM): a partner and part of the European ECNM network 

H. Pehamberger, P. Valent, W. Sperr, 2013, memo - Magazine of European Medical Oncology.

Limitations of high frequency ultrasound in determining the invasiveness of cutaneous malignant melanoma

M. Binder, H. Pehamberger, K. Wolff, 1996, Melanoma research.

Isolation and structural analysis of peptide mimotopes for the disialoganglioside GD2, a neuroblastoma tumor antigen.

Anna Katharina Dehof, H. Pehamberger, A. Riemer, 2005, Molecular immunology.

Clusterin regulates drug-resistance in melanoma cells.

H. Pehamberger, M. Gleave, V. Sexl, 2005, The Journal of investigative dermatology.

Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo

P. Tschandl, H. Kittler, H. Pehamberger, 2016, The British journal of dermatology.

Trophoblast invasion: assessment of cellular models using gene expression signatures.

H. Pehamberger, O. Wagner, M. Bilban, 2010, Placenta.

Mcl-1 blocks radiation-induced apoptosis and inhibits clonogenic cell death.

H. Pehamberger, B. Monia, C. Thallinger, 2005, Anticancer research.

Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her‐2/neu

H. Pehamberger, C. Radauer, S. Wagner, 2003, International journal of cancer.

Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice

H. Pehamberger, K. Wolff, H. Eichler, 1999, International journal of cancer.

Comparative histopathology of grey-horse-melanoma and human malignant melanoma.

H. Pehamberger, B. Jansen, M. Seltenhammer, 2004, Pigment cell research.

Morphologic changes of pigmented skin lesions: A useful extension of the ABCD rule for dermatoscopy

H. Kittler, M. Binder, H. Pehamberger, 1998 .

CpG oligonucleotides elicit antitumor responses in a human melanoma NOD/SCID xenotransplantation model.

H. Pehamberger, K. Wolff, G. Hartmann, 2004, The Journal of investigative dermatology.

A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study

H. Pehamberger, G. Steger, C. Wiltschke, 2010, Breast Cancer Research and Treatment.

Continuous systemic corticosteroids do not affect the ongoing regression of metastatic melanoma for more than two years following ipilimumab therapy

M. Binder, H. Pehamberger, K. Harmankaya, 2011, Medical oncology.

Episodic angioedema with eosinophilia.

H. Pehamberger, K. Wolff, S. Breyer, 1989, Journal of the American Academy of Dermatology.

Systemic lupus erythematosus with multiple myeloma.

H. Pehamberger, E. Diem, K. Konrad, 1978, Acta dermato-venereologica.

The human orthologue of a novel apoptosis response gene induced during rat myelomonocytic stem cell apoptosis maps to 20q13.12.

H. Pehamberger, Markus Müller, Poul H. B. Sorensen, 2005, Stem cells and development.

Efficacy and safety of ipilimumab induction and maintenance dosing in patients with advanced melanoma who progressed on one or more prior therapies

H. Pehamberger, V. Chiarion-Sileni, M. Maio, 2008 .

Human Determinants and the Role of Melanocortin-1 Receptor Variants in Melanoma Risk Independent of UV Radiation Exposure.

H. Pehamberger, S. Burgstaller-Muehlbacher, G. Fischer, 2016, JAMA dermatology.

Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma.

H. Kittler, H. Pehamberger, S. Schoppmann, 2004, European journal of cancer.

Novel efficacy criteria for antitumor activity to immunotherapy using the example of ipilimumab, an anti-CTLA-4 monoclonal antibody

H. Pehamberger, J. Wolchok, F. Hodi, 2008 .

Dysplastic nevus syndrome with multiple primary amelanotic melanomas in oculocutaneous albinism.

H. Hönigsmann, H. Pehamberger, K. Wolff, 1984, Journal of the American Academy of Dermatology.

Specificity of Mimotope-Induced Anti-High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Antibodies Does Not Ensure Biological Activity

H. Pehamberger, S. Gaier, S. Wagner, 2011, PloS one.

Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.

A. Steiner, H. Pehamberger, W. Aberer, 2016, Acta dermato-venereologica.

Dermal infiltrates of cutaneous T‐cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin+ dendritic cells

H. Pehamberger, G. Klosner, F. Trautinger, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes

H. Pehamberger, A. Riemer, C. Zielinski, 2006, European journal of immunology.

Penetration of dacarbazine and its active metabolite 5‐aminoimidazole‐4‐carboxamide into cutaneous metastases of human malignant melanoma

H. Pehamberger, B. Rizovski, R. Mader, 2001, Cancer.

Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters

H. Pehamberger, H. Wolf, W. Bauer, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis.

H. Pehamberger, C. Zielinsky, W. Silny, 1980, The Journal of investigative dermatology.

Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2

H. Pehamberger, M. Freissmuth, M. Micksche, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.

H. Pehamberger, W. Pickl, P. Valent, 2010, Experimental hematology.

Possible hazard to patients from immersion oil used for epiluminescence microscopy.

H. Kittler, M. Binder, H. Pehamberger, 1999, Journal of the American Academy of Dermatology.

Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice

H. Pehamberger, S. Wagner, H. Breiteneder, 2007, Breast Cancer Research and Treatment.

Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).

H. Pehamberger, P. Valent, W. Sperr, 2013, American journal of blood research.

Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis.

H. Pehamberger, K. Wolff, H. Eichler, 1997, Cancer Research.

Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice

H. Pehamberger, K. Wolff, Y. Kloog, 1999, Journal of Molecular Medicine.

Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism.

H. Pehamberger, K. Wolff, H. Eichler, 1995, Antisense research and development.

Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNP-modified syngeneic cells: requirement for Ia-positive Langerhans cells.

H. Pehamberger, K. Wolff, G. Stingl, 1983, The Journal of investigative dermatology.

Immunoelectron Microscopy of Skin in Lupus Erythematosus

H. Pehamberger, K. Holubar, K. Konrad, 1978, Journal of cutaneous pathology.

A phase I study to evaluate safety, immunogenicity and antitumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer

H. Pehamberger, C. Wiltschke, C. Zielinski, 2008 .

High-molecular-weight melanoma-associated antigen mimotope immunizations induce antibodies recognizing melanoma cells

H. Pehamberger, A. Riemer, C. Zielinski, 2005, Cancer Immunology, Immunotherapy.

Effect of BCG on concanavalin A-induced suppressor cell activity and lymphocyte stimulation in stage I melanoma.

H. Pehamberger, W. Knapp, 1981, The Journal of investigative dermatology.

Loss of novel mda-7 splice variant (mda-7s) expression is associated with metastatic melanoma.

H. Pehamberger, F. Roka, M. Allen, 2004, The Journal of investigative dermatology.

Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight‐melanoma associated antigen (HMW‐MAA) specific monoclonal antibody

H. Pehamberger, K. Wolff, S. Wagner, 2005, International journal of cancer.

Reduction of Human Melanoma Tumor Growth in Severe Combined Immunodeficient Mice by Passive Transfer of Antibodies Induced by a High Molecular Weight Melanoma-Associated Antigen Mimotope Vaccine

H. Pehamberger, S. Wagner, H. Breiteneder, 2008, Clinical Cancer Research.

Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization

H. Pehamberger, K. Wolff, C. Marosi, 1999, British Journal of Cancer.

Indomethacin does not affect PUVA induced erythema

H. Pehamberger, F. Gschnait, 1977, Archives of Dermatological Research.

Cisplatin‐induced renal effects and thromboxane A2 receptor blockade

H. Pehamberger, M. Wolzt, H. Eichler, 1997, European journal of clinical investigation.

Effects of cisplatin on urinary thromboxane B2 excretion

H. Pehamberger, H. Eichler, P. Kyrle, 1995, Clinical pharmacology and therapeutics.

Sentinel node status in melanoma patients is not predicitive for overall survival upon multivariate analysis

H. Kittler, H. Pehamberger, K. Wolff, 2005, British Journal of Cancer.

Ammoniated mercury ointment: outdated but still in use

H. Pehamberger, W. Aberer, G. Gerstner, 1990, Contact dermatitis.

Computer aided recognition of pigmented skin lesion: 066

Harald Ganster, Axel Pinz, Michael Binder, 1997 .

Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk

Michael Binder, Harald Kittler, Alexandra Harbauer, 2003, Melanoma research.

Guidelines for the planning and implementation of telemedical applications

M. Binder, H. Pehamberger, W. Dorda, 2005, Wiener klinische Wochenschrift.

A rare case of primary rhabdoid melanoma of the urinary bladder treated with ipilimumab, an anti-CTLA 4 monoclonal antibody

H. Pehamberger, K. Harmankaya, A. Haitel, 2012, Melanoma research.

Tetrasomy 8 in acute monoblastic leukemia (AML-M5a) with myelosarcomatosis of the skin.

H. Pehamberger, C. Marosi, O. Haas, 1993, Cancer genetics and cytogenetics.

Development of a treatment algorithm for actinic keratoses: a European Consensus.

H. Pehamberger, H. Kerl, J. Grob, 2008, European journal of dermatology : EJD.

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.

M. Binder, A. Seeber, A. Steiner, 1998, European journal of cancer.

A novel concept for ligand attachment to oligonucleotides via a 2'-succinyl linker.

H. Pehamberger, C. Noe, V. Wacheck, 2004, Nucleic acids research.

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

J. Malvehy, H. Pehamberger, K. Peris, 2015, European journal of cancer.

Failure to detect gliadin or gliadin binding sites in the skin of patients with dermatitis herpetiformis: immunofluorescence, organ culture and autoradiographic studies.

H. Pehamberger, K. Holubar, F. Gschnait, 1979, The Journal of investigative dermatology.

Effects of betulinic acid alone and in combination with irradiation in human melanoma cells.

H. Pehamberger, B. Jansen, E. Pimentel, 2000, The Journal of investigative dermatology.

[Secondary cutaneous mycoses caused by Alternaria species].

H. Pehamberger, O. Male, 1986, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Ultrastructural and Immunological Findings in Graves' Disease with Pretibial Myxedema *

H. Pehamberger, W. Brenner, K. Konrad, 1980, Journal of cutaneous pathology.

Sulfone treatment of granuloma annulare.

A. Steiner, H. Pehamberger, K. Wolff, 1985, Journal of the American Academy of Dermatology.

Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant?

H. Pehamberger, K. Wolff, R. Strohal, 1993, Journal of the American Academy of Dermatology.

Circulating IgA anti-basement membrane antibodies in linear dermatitis herpetiformis (Duhring): immunofluorescence and immunoelectronmicroscopic studies.

H. Pehamberger, K. Holubar, K. Konrad, 1977, The Journal of investigative dermatology.

Ultrastructural localization of immunoglobulin and fibrin in lichen planus.

H. Pehamberger, K. Holubar, K. Konrad, 1979, Journal of the American Academy of Dermatology.

Inhibition of DNA synthesis of melanoma cells by azelaic acid.

H. Pehamberger, K. Wolff, G. Stingl, 1985, The Journal of investigative dermatology.

Epiluminescence microscopy of small pigmented skin lesions: short-term formal training improves the diagnostic performance of dermatologists.

K Wolff, H. Kittler, M. Binder, 1997, Journal of the American Academy of Dermatology.

Mechanism of UV-B-induced impairment of the antigen-presenting capacity of murine epidermal cells.

H. Pehamberger, K. Wolff, M. Iijima, 1983, Journal of immunology.

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.

I. Zalaudek, J. Becker, J. Malvehy, 2015, European journal of cancer.

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

J. Becker, J. Malvehy, H. Pehamberger, 2015, European journal of cancer.

Epidermal Langerhans cells can function as stimulatory cells but not as accessory cells in CTL induction.

H. Pehamberger, M. Iijima, G. Shearer, 1984, Journal of immunology.

Diagnosis and Treatment of Melanoma. European Consensus ⴀbased Interdisciplinary Guideline Developed by the Guideline Subcommittee of the

A. Hauschild, J. Malvehy, H. Pehamberger, 2012 .

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline.

Josep Malvehy, Axel Hauschild, Jean-Jacques Grob, 2010, European journal of cancer.

Interferon resistance promotes oncolysis by influenza virus NS1‐deletion mutants

H. Pehamberger, K. Wolff, A. García-Sastre, 2004, International journal of cancer.

Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.

M. Binder, A. Steiner, H. Pehamberger, 1998, The American Journal of dermatopathology.

Generation of Peptide Mimics of the Epitope Recognized by Trastuzumab on the Oncogenic Protein Her-2/neu1

Markus Klinger, Angelika B. Riemer, Stefan Wagner, 2004, The Journal of Immunology.

Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group.

M. Binder, A. Steiner, H. Pehamberger, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pigmented Spitz nevi: improvement of the diagnostic accuracy by epiluminescence microscopy.

K Wolff, M. Binder, A. Steiner, 1992, Journal of the American Academy of Dermatology.

Recombinant leukocyte A interferon and cimetidine treatment in disseminated melanoma.

A. Steiner, H. Pehamberger, K. Wolff, 1986, European journal of cancer & clinical oncology.

Diffuse melanosis in metastatic malignant melanoma.

A. Steiner, H. Pehamberger, V. Groh, 1991, Journal of the American Academy of Dermatology.

An endogenous retrovirus derived from human melanoma cells.

H. Pehamberger, K. Wolff, D. Födinger, 2003, Cancer research.

Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction

H. Pehamberger, P. Petzelbauer, C. Gerner, 2012, PloS one.

Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes

S. Spiegl-Kreinecker, C. Pirker, W. Berger, 2003, Melanoma research.

Combination allele-specific real-time PCR for differentiation of beta 2-adrenergic receptor coding single-nucleotide polymorphisms.

H. Pehamberger, L. Schmetterer, M. Wolschek, 2004, Clinical chemistry.

Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplatation model.

H. Pehamberger, K. Wolff, C. Thallinger, 2005, The Journal of investigative dermatology.

Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.

H. Pehamberger, M. Gore, J. Kirkwood, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A variant in FTO shows association with melanoma risk not due to BMI

Marko Hočevar, Florence Demenais, Kari Stefansson, 2013, Nature Genetics.

Betulinic Acid-induced Mcl-1 Expression in Human Melanoma — Mode of Action and Functional Significance

H. Pehamberger, C. Thallinger, B. Jansen, 2002, Molecular medicine.

Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses.

Bernd Mayer, Andreas Grassauer, Johannes Humer, 2006, Cancer research.

Diagnosis and treatment of melanoma . European consensus-based interdisciplinary guideline e Update 2016

Josep Malvehy, Axel Hauschild, Jean-Jacques Grob, 2016 .

Neoplastic stem cells: current concepts and clinical perspectives.

H. Pehamberger, U. Jäger, P. Valent, 2010, Critical reviews in oncology/hematology.

[Tumor stem cell research - basis and challenge for diagnosis and therapy].

H. Pehamberger, U. Jäger, P. Valent, 2010, Wiener klinische Wochenschrift.

Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma

H. Pehamberger, J. Humer, A. Waltenberger, 2011, Pigment cell & melanoma research.

Identification of genetic disparity between primary and metastatic melanoma in human patients

H. Pehamberger, P. Petzelbauer, I. Okamoto, 2011, Genes, chromosomes & cancer.

The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.

H. Pehamberger, D. Fisher, P. Valent, 2002, Cancer research.

Expression of Bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines

H. Pehamberger, B. Jansen, I. Okamoto, 1998, Melanoma research.

NF-k B is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

H. Pehamberger, H. Beug, T. Wirth, 2018 .

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

H. Pehamberger, J. Wolchok, P. Queirolo, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Characterization of NKIP: a novel, Na+/K+-ATPase interacting protein mediates neural differentiation and apoptosis.

H. Pehamberger, M. Wolschek, C. Thallinger, 2008, Experimental cell research.

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.

Josep Malvehy, Axel Hauschild, Jean-Jacques Grob, 2012, European journal of cancer.

Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts

C. Pirker, W. Berger, H. Pehamberger, 2015, Molecular Cancer Therapeutics.

Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.

H. Pehamberger, P. Pötzi, W. Knapp, 1980, British Journal of Cancer.

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.

H. Pehamberger, H. Beug, T. Wirth, 2004, The Journal of clinical investigation.

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.

M. Binder, H. Pehamberger, F. Roka, 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.

H. Pehamberger, F. Trautinger, A. Haitel, 2011, Journal of dermatological science.

NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi

P. Tschandl, H. Kittler, H. Pehamberger, 2013, PloS one.

Dimethylfumarate impairs melanoma growth and metastasis.

H. Pehamberger, P. Petzelbauer, R. Kunstfeld, 2006, Cancer research.

The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells

H. Pehamberger, M. Herlyn, K. Nathanson, 2013, Clinical Cancer Research.

Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I study.

H. Kittler, H. Pehamberger, K. Wolff, 1999, Human gene therapy.

Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis.

A. Steiner, H. Pehamberger, A. Bracher, 2013, The Journal of investigative dermatology.

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline--Update 2012.

A. Hauschild, J. Malvehy, H. Pehamberger, 2012, European journal of cancer.

Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma.

H. Pehamberger, L. Prayer, N. Gritzmann, 1990, European journal of cancer.

Temozolomide and interferon α2b in metastatic melanoma stage IV

R. Hofmann-Wellenhof, A. Seeber, A. Steiner, 2004 .

Leishmaniasis in the tongue of an immunocompetent man.

M. Binder, H. Pehamberger, K. Harmankaya, 2010, The American journal of tropical medicine and hygiene.

Functional Classification of Cellular Proteome Profiles Support the Identification of Drug Resistance Signatures in Melanoma Cells

T. Mohr, W. Berger, H. Pehamberger, 2013, Journal of proteome research.

Transcriptome analysis of human cancer reveals a functional role of Heme Oxygenase-1 in tumor cell adhesion

H. Pehamberger, O. Wagner, M. Mayerhofer, 2010, Molecular Cancer.

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives

H. Pehamberger, T. Rülicke, U. Jäger, 2018, Wiener klinische Wochenschrift.

Elective regional lymph node dissection in malignant melanoma.

M. Binder, A. Steiner, H. Pehamberger, 1990, European Journal of Cancer.

Novel Ras antagonist blocks human melanoma growth.

H. Pehamberger, K. Wolff, B. Mayer, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis.

H. Pehamberger, A. Bracher, P. Petzelbauer, 2010, The Journal of investigative dermatology.

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial.

C. Berking, A. Hauschild, D. Schadendorf, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Small interfering RNA targeting bcl-2 sensitizes malignant melanoma.

H. Pehamberger, A. Geick, P. Hadwiger, 2003, Oligonucleotides.

Equine melanoma in a population of 296 grey Lipizzaner horses.

H. Pehamberger, J. Sölkner, B. Jansen, 2010, Equine veterinary journal.

Pegylated and conventional interferon-alpha induce comparable transcriptional responses and inhibition of tumor growth in a human melanoma SCID mouse xenotransplantation model.

H. Pehamberger, K. Wolff, U. Certa, 2004, Journal of Investigative Dermatology.

New common variants affecting susceptibility to basal cell carcinoma

D. Gudbjartsson, A. Sigurdsson, T. Blondal, 2009, Nature Genetics.

Site‐dependent actinic skin damage as risk factor for melanoma in a central European population

M. Binder, H. Pehamberger, J. Wendt, 2012, Pigment cell & melanoma research.

In vivo dual-modality photoacoustic and optical coherence tomography imaging of human dermatological pathologies.

Boris Hermann, Wolfgang Drexler, Mengyang Liu, 2015, Biomedical optics express.

3,3 0 ,4,4 0 ,5,5 0 -Hexahydroxystilbene Impairs Melanoma Progression in a Metastatic Mouse Model

H. Pehamberger, A. Riemer, T. Szekeres, 2010 .

Activin A is anti-lymphangiogenic in a melanoma mouse model.

H. Pehamberger, M. Grusch, P. Petzelbauer, 2015, The Journal of investigative dermatology.

Expression of stromal cell markers in distinct compartments of human skin cancers

H. Pehamberger, M. A. Huber, N. Kraut, 2006, Journal of cutaneous pathology.

Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macro-metastatic nodes: EADO trial.

A. Hauschild, H. Pehamberger, M. Landthaler, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.

M. Weichenthal, A. Hauschild, H. Pehamberger, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temozolomide and interferon alpha 2b in metastatic melanoma stage IV.

R. Hofmann-Wellenhof, A. Seeber, A. Steiner, 2004, The British journal of dermatology.

Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients

H. Kittler, H. Pehamberger, K. Wolff, 2001, Melanoma research.

Influenza Virus NS1 Protein Counteracts PKR-Mediated Inhibition of Replication

Adolfo Garcia-Sastre, H. Pehamberger, A. García-Sastre, 2000, Journal of Virology.

Association between immune-related adverse events (irAEs) and disease control or overall survival in patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials.

H. Pehamberger, G. Linette, J. Wolchok, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression

H. Kittler, H. Pehamberger, K. Wolff, 2001, Melanoma research.

Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: an open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study.

A. Hauschild, H. Pehamberger, M. Landthaler, 2013, European journal of cancer.

Characterization of patients at high risk of melanoma in Austria

H. Pehamberger, S. Burgstaller-Muehlbacher, E. Richtig, 2016, The British journal of dermatology.

First comparative delineation of the T cell receptor repertoire in primary and multiple subsequent/coexisting metastatic melanoma sites.

H. Pehamberger, G. Stingl, R. Strohal, 1998, The Journal of investigative dermatology.

Correlation of absolute and relative eosinophil counts with immune-related adverse events in melanoma patients treated with ipilimumab.

H. Pehamberger, R. Dummer, J. Wolchok, 2014 .

Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.

H. Pehamberger, K. Wolff, G. Stingl, 1985, Journal of immunology.

Computer assisted estimation of the volume weighted mean nuclear volume discriminates Spitz's nevi from malignant melanomas

M. Binder, A. Steiner, H. Pehamberger, 1993 .

Effect of BCG on monocyte‐mediated antibody‐dependent cellular cytotoxicity in stage I melanoma

H. Pehamberger, W. Knapp, K. Holubar, 1980, Cancer.

Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis.

A. Fassolt, H. Pehamberger, H. Eichler, 1996, British Journal of Cancer.

Adjuvant interferon alpha-2a treatment in resected primary cutaneous melanoma: 108

M. Binder, A. Steiner, H. Pehamberger, 1997 .

Effect of ipilimumab treatment on 18-month survival: Update of patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials.

H. Pehamberger, J. Wolchok, K. Harmankaya, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lymph node sonography versus palpation for detecting recurrent disease in patients with malignant melanoma.

H. Kittler, M. Binder, A. Steiner, 1997, European Journal of Cancer.

Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM)

H. Pehamberger, M. Gore, J. Kirkwood, 2005 .

Cross-reactivity of mimotopes with a monoclonal antibody against the high molecular weight melanoma-associated antigen (HMW-MAA) does not predict cross-reactive immunogenicity

H. Pehamberger, A. Riemer, S. Wagner, 2005, Melanoma research.

Langerhans cell-containing epidermal cells are not cytotoxic in antibody-dependent- and mitogen-induced-cellular cytotoxicity.

H. Pehamberger, P. Henkart, S. Katz, 1982, Immunobiology.

Late metastases of cutaneous malignant melanoma

A. Steiner, H. Pehamberger, K. Wolff, 1986, The British journal of dermatology.

Pretherapeutic laboratory findings, extent of metastasis and choice of treatment as prognostic markers in ocular melanoma– a single centre experience

H. Pehamberger, K. Harmankaya, C. Hoeller, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma.

H. Pehamberger, O. Wagner, F. Roka, 2006, The Journal of investigative dermatology.

T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.

H. Pehamberger, G. Stingl, R. Strohal, 1994, Cancer research.

Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma.

M. Binder, H. Pehamberger, K. Wolff, 1992, The Journal of investigative dermatology.

Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma

H. Pehamberger, M. Mildner, E. Tschachler, 1999, British Journal of Cancer.

EFFICACY AND SAFETY OF IPILIMUMAB IN PATIENTS WITH ADVANCED MELANOMA WHO HAD PROGRESSED ON ONE OR MORE PRIOR THERAPIES: RESULTS FROM A SINGLE-ARM, MULTICENTER STUDY

H. Pehamberger, J. Wolchok, M. Maio, 2008 .

[Neurotrophic ulcerations in the trigeminal region].

H. Pehamberger, N. Mayr, E. Sorger, 1981, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.

C. Pirker, W. Berger, H. Pehamberger, 2005, Neoplasia.

[Melanoma of the vulva. Report of 12 cases].

H. Pehamberger, M. Seifert, N. Vávra, 1991, Geburtshilfe und Frauenheilkunde.

Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma

H. Pehamberger, C. Hoeller, V. Paulitschke, 2009, Clinical Cancer Research.

Vaccination with a Human High Molecular Weight Melanoma-Associated Antigen Mimotope Induces a Humoral Response Inhibiting Melanoma Cell Growth In Vitro1

H. Pehamberger, S. Wagner, H. Breiteneder, 2005, The Journal of Immunology.

Inhibiting Melanoma Cell Growth In Vitro Mimotope Induces a Humoral Response Weight Melanoma-Associated Antigen Vaccination with a Human High Molecular

H. Pehamberger, S. Wagner, H. Breiteneder, 2004 .

Juvenile dermatitis herpetiformis: an immunoelectron microscopic study

H. Pehamberger, K. Holubar, K. Konrad, 1979, The British journal of dermatology.

Recognized by Trastuzumab on the Generation of Peptide Mimics of the Epitope

H. Pehamberger, L. Mazzucchelli, S. Wagner, 2013 .

Defective interferon-augmented natural killer cell activity in patients with metastatic malignant melanoma

M. Binder, H. Pehamberger, C. Zielinski, 2004, Journal of Cancer Research and Clinical Oncology.

Differential expression levels of Par-4 in melanoma

H. Pehamberger, K. Wolff, H. Eichler, 2001, Melanoma research.

The hsp27kD heat shock protein and p38-MAPK signaling are required for regular epidermal differentiation.

H. Pehamberger, M. Mildner, E. Tschachler, 2011, Journal of dermatological science.

Quantification of vascularity in nodular melanoma and Spitz's nevus

M. Binder, A. Steiner, H. Pehamberger, 1997, Journal of cutaneous pathology.

BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression.

Harald J. Maier, H. Pehamberger, J. Madwed, 2010, Genes & cancer.

Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results

H. Pehamberger, T. Thalhammer, I. Virgolini, 2005, Melanoma research.

Erythropoietin receptor expression in human melanoma cells

H. Pehamberger, B. Jansen, V. Wacheck, 2000, Melanoma research.

Treatment with an oral aromatic retinoid in linear porokeratosis.

H. Pehamberger, K. Konrad, 1980, Dermatologica.

[Oral leukoedema--sequela of an artifact].

H. Pehamberger, V. Groh, C. Wolf, 1986, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

Transient acantholytic dermatosis Grover.

H. Pehamberger, K. Holubar, K. Konrad, 1977, Zeitschrift fur Hautkrankheiten.

Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody.

H. Pehamberger, J. Wolchok, C. Ariyan, 2013 .

Use of the ophthalmoscope in the clinical diagnosis of cutaneous pigmented lesions

H. Pehamberger, Keyoumars SoltanL, 2008 .

[Diagnostic criteria in epiluminescence microscopy. Consensus meeting of the professional committee of analytic morphology of the Society of Dermatologic Research, 17 November 1989 in Hamburg].

J. Kreusch, H. Pehamberger, W. Stolz, 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen's Disease of the Hand.

H. Pehamberger, F. Thalhammer, P. Petzelbauer, 2019, Acta dermato-venereologica.

Frequency and characteristics of enlarging common melanocytic nevi.

H. Kittler, M. Binder, H. Pehamberger, 2000, Archives of Dermatology.

Initial results of automated melanoma recognition

Harald Ganster, Axel Pinz, Michael Binder, 1996 .

Prognostic relevance of hypoxia inducible factor‐1α expression in patients with melanoma

H. Kittler, H. Pehamberger, K. Schmid, 2009, Clinical and experimental dermatology.

Technetium-99m-tetrofosmin: a new agent for melanoma imaging?

H. Pehamberger, G. Karanikas, B. Jansen, 1998, Anticancer Research.

Demonstration of antibodies to wheat gliadin in dermatitis herpetiformis using 14C-radioimmunoassay.

H. Pehamberger, E. Menzel, K. Holubar, 1978, Clinical immunology and immunopathology.

A microsatellite polymorphism in the heme oxygenase‐1 gene promoter is associated with risk for melanoma

H. Pehamberger, O. Wagner, C. Mannhalter, 2006, International journal of cancer.

Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.

H. Pehamberger, K. Wolff, S. Wagner, 2005, The Journal of investigative dermatology.

Immediate effects of a public education campaign on prognostic features of melanoma.

K Wolff, M. Binder, H. Pehamberger, 1993, Journal of American Academy of Dermatology.

Original Paper Lymph Node Sonography Versus Palpation for Detecting Recurrent Disease in Patients with Malignant Melanoma

H. Kittler, M. Binder, A. Steiner, 1997 .

Alternative splicing of IL‐24 in melanocytes by deletion of exons 3 and 5

H. Pehamberger, M. Allen, T. Lucas, 2005, International journal of immunogenetics.

Diagnostic informativeness of compressed digital epiluminescence microscopy images of pigmented skin lesions compared with photographs

H. Kittler, M. Binder, H. Pehamberger, 1998, Melanoma research.

Antitumor effect of G3139 Bcl-2 antisense oligonucleotide is independent of its immune stimulation by CpG motifs in SCID mice.

H. Pehamberger, H. Eichler, B. Jansen, 2002, Antisense & nucleic acid drug development.

P007. Comprehensive analysis of phenotypic risk factors of melanoma in a central European population

M. Binder, H. Pehamberger, J. Wendt, 2011 .

Induction of Cell‐Mediated Cytotoxic Self Responses by Epidermal Cells Modified with a Haptenic Sulphydryl Reagent

H. Pehamberger, P. Henkart, R. Levy, 1982, Scandinavian journal of immunology.

Oral treatment of ichthyosis with an aromatic retinoid

H. Pehamberger, K. Holubar, H. Neumann, 1978, The British journal of dermatology.

[Clinical value of a dermatoscopic classification of Clark nevi].

H. Kittler, M. Binder, H. Pehamberger, 2003, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Active induction of tumor-specific IgE antibodies by oral mimotope vaccination.

H. Pehamberger, A. Riemer, E. Untersmayr, 2007, Cancer research.

767O TREATMENT OF PATIENTS WITH ADVANCED REFRACTORY OR RELAPSED MELANOMA IN A PHASE II STUDY OF TREMELIMUMAB (CP-675,206), AN ANTI-CTLA4 MONOCLONAL ANTIBODY

A. Hauschild, D. Schadendorf, H. Pehamberger, 2008 .

P32 Erlotinib in combination with different chemotherapeutics is active in a SCID mouse/human melanoma model

H. Pehamberger, C. Hoeller, N. Schicher, 2010 .

A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).

H. Kittler, M. Binder, H. Pehamberger, 2001, Wiener klinische Wochenschrift.

Azelaic acid decreases the fibrinolytic potential of cultured human melanoma cells in vitro.

P. Hufnagl, H. Pehamberger, B. Binder, 1996, Cancer letters.

Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM).

H. Pehamberger, P. Valent, W. Sperr, 2013, American journal of blood research.